373 related articles for article (PubMed ID: 22303484)
1. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
[TBL] [Abstract][Full Text] [Related]
2. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
[TBL] [Abstract][Full Text] [Related]
3. Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
Heydari R; Fayazzadeh S; Shahrokh S; Shekari F; Farsad F; Meyfour A
Inflamm Bowel Dis; 2024 May; 30(5):795-807. PubMed ID: 37855715
[TBL] [Abstract][Full Text] [Related]
4. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
5. Serum galectins as potential biomarkers of inflammatory bowel diseases.
Yu TB; Dodd S; Yu LG; Subramanian S
PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
[TBL] [Abstract][Full Text] [Related]
6. Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study.
Jagt JZ; Struys EA; Ayada I; Bakkali A; Jansen EEW; Claesen J; van Limbergen JE; Benninga MA; de Boer NKH; de Meij TGJ
Inflamm Bowel Dis; 2022 May; 28(5):755-763. PubMed ID: 34757415
[TBL] [Abstract][Full Text] [Related]
7. Amino acids-targeted metabolomics reveals novel diagnostic biomarkers for ulcerative colitis and Crohn's disease.
Zhou G; Liu H; Wei P; He Q; Zhang J; Shi Q; Liu T; Liu S
Amino Acids; 2023 Mar; 55(3):349-358. PubMed ID: 36625991
[TBL] [Abstract][Full Text] [Related]
8. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
9. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
[TBL] [Abstract][Full Text] [Related]
13. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases.
Quénéhervé L; David G; Bourreille A; Hardouin JB; Rahmi G; Neunlist M; Brégeon J; Coron E
Gastrointest Endosc; 2019 Mar; 89(3):626-636. PubMed ID: 30120955
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
[TBL] [Abstract][Full Text] [Related]
17. Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.
Kalla R; Kennedy NA; Ventham NT; Boyapati RK; Adams AT; Nimmo ER; Visconti MR; Drummond H; Ho GT; Pattenden RJ; Wilson DC; Satsangi J
Am J Gastroenterol; 2016 Dec; 111(12):1796-1805. PubMed ID: 27596694
[TBL] [Abstract][Full Text] [Related]
18. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.
Bodelier AG; Pierik MJ; Lenaerts K; de Boer E; Olde Damink SW; Hameeteman WM; Masclee AA; Jonkers DM
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):807-13. PubMed ID: 26919325
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
Yoshimura T; Mitsuyama K; Sakemi R; Takedatsu H; Yoshioka S; Kuwaki K; Mori A; Fukunaga S; Araki T; Morita M; Tsuruta K; Yamasaki H; Torimura T
Mediators Inflamm; 2021; 2021():8825374. PubMed ID: 33623482
[TBL] [Abstract][Full Text] [Related]
20. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
Clerc F; Novokmet M; Dotz V; Reiding KR; de Haan N; Kammeijer GSM; Dalebout H; Bladergroen MR; Vukovic F; Rapp E; ; Targan SR; Barron G; Manetti N; Latiano A; McGovern DPB; Annese V; Lauc G; Wuhrer M
Gastroenterology; 2018 Sep; 155(3):829-843. PubMed ID: 29792883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
